Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Rating of “Hold” from Brokerages

Shares of Ardent Health, Inc. (NYSE:ARDT) have been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $14.5833.

ARDT has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a report on Tuesday, January 20th. Leerink Partners set a $16.00 target price on Ardent Health in a research report on Friday, November 14th. Royal Bank Of Canada lowered their price target on Ardent Health from $21.00 to $16.00 and set an “outperform” rating for the company in a research report on Friday, November 14th. Truist Financial reduced their price target on Ardent Health from $21.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday, November 14th. Finally, Bank of America dropped their price objective on Ardent Health from $12.00 to $10.00 and set an “underperform” rating on the stock in a report on Thursday, November 13th.

Institutional Investors Weigh In On Ardent Health

A number of hedge funds and other institutional investors have recently modified their holdings of ARDT. Geode Capital Management LLC grew its position in Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,769 shares during the period. CWM LLC lifted its holdings in Ardent Health by 990.6% in the second quarter. CWM LLC now owns 2,203 shares of the company’s stock worth $30,000 after acquiring an additional 2,001 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Ardent Health by 8.3% in the second quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company’s stock worth $376,000 after buying an additional 2,110 shares during the period. Strs Ohio increased its stake in shares of Ardent Health by 6.3% in the third quarter. Strs Ohio now owns 42,400 shares of the company’s stock valued at $562,000 after purchasing an additional 2,500 shares during the period. Finally, Alliancebernstein L.P. raised its stake in shares of Ardent Health by 24.8% during the third quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock valued at $218,000 after purchasing an additional 3,272 shares in the last quarter.

Ardent Health Stock Up 1.4%

NYSE:ARDT opened at $9.48 on Friday. The firm has a market capitalization of $1.36 billion, a P/E ratio of 6.54, a PEG ratio of 5.42 and a beta of 0.72. The company’s fifty day moving average price is $8.78 and its 200-day moving average price is $11.21. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.08 and a quick ratio of 1.95. Ardent Health has a 1-year low of $8.07 and a 1-year high of $15.59.

Ardent Health (NYSE:ARDT) last posted its earnings results on Wednesday, November 12th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.42 by $0.10. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. As a group, equities research analysts anticipate that Ardent Health will post 1.23 EPS for the current year.

Ardent Health News Roundup

Here are the key news stories impacting Ardent Health this week:

• Positive Sentiment: Ardent set its fourth quarter and full‑year 2025 results release for after the close on March 4, 2026, with a conference call/webcast on March 5; the report is a near‑term catalyst that could reduce uncertainty about the company’s receivables and reserves. Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date
• Negative Sentiment: Hagens Berman is investigating alleged accounting problems tied to a reported “180‑day cliff” reserve approach and an asserted ~$97M collectability shock disclosed in November 2025 — the allegation questions prior statements about receivables valuation and is a direct driver of investor losses cited in the lawsuits. ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT)
• Negative Sentiment: Multiple national plaintiff firms have filed or solicited clients for securities class actions (Bleichmar Fonti & Auld, Rosen, Levi & Korsinsky, Pomerantz, Faruqi, Gross, Schall, ClaimsFiler, Glancy, Kahn Swick & Foti, etc.), citing a steep share decline after the collectability disclosure; firms are pushing the March 9 lead‑plaintiff deadline — litigation exposure, potential settlements and management distraction are key downside risks. ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.